Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Long-term efficacy and safety of alemtuzumab in patients with RRMS: 12-year follow-up of CAMMS223.
Journal: Journal of neurology
Published: March 06, 2020
Lymphocyte pharmacodynamics are not associated with autoimmunity or efficacy after alemtuzumab.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: May 15, 2019
Comparative effectiveness of dimethyl fumarate versus fingolimod and teriflunomide among MS patients switching from first-generation platform therapies in the US.
Journal: Multiple sclerosis and related disorders
Published: June 20, 2018
Showing 1-3 of 3
Last Updated: 09/26/2026